<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Publication Alert: Q317 Wound Care Surgical Matrices Quarterly Market Recap

Posted by Doug Devens on 12/19/17 2:04 PM

SmartTRAK Publication Alert Blog Post Social Media - Wound Care - Surgical Matrices.png

Q317 US Surgical Matrices Market: Strong Growth Continues in Breast Matrices 

The US Surgical Matrices Market saw growth in Q317 as sales of allografts fueled double-digit growth in breast matrices and biosynthetics offset declines in biologics in hernia repair.

By Doug Devens, Senior Analyst Biosurgery

The US Surgical Matrices market, consisting of hernia repair and breast reconstruction products, continued uneven growth in Q317.  Allergan continued to capture share in the overall market, using its growth in allografts to increase its share.

The Q317 US Hernia Repair Matrices market (consisting of synthetics, biologics and biosynthetic), again had minimal gains,  as significant declines continued in biologics (allografts and xenografts) while synthetics held steady according to BioMedGPS’ SmartTRAK Financial Dashboard. While synthetics continue to hold the largest share at...

Read entire Market Recap including news, data and analysis*...

*This article can only be viewed by SmartTRAK subscribers to this module.

Request SmartTRAK Wound Care Subscription Info

Topics: Advanced Wound Care-Surgical Matrices

Subscribe to News and Analysis Blog Weekly Emails

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies. 

Recent Posts